What Clinicians Need to Know About the Development of Long-Acting Formulations

Charles Flexner, David L. Thomas, Polly Clayden, Susan Swindells

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S487-S489
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue number4
StatePublished - Nov 21 2022


  • HIV prevention
  • HIV treatment
  • long-acting formulations
  • tuberculosis
  • viral hepatitis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this